Investments in linker and conjugation technologies are now the main focus for ADC drug developers. Join pioneers and industry leaders in Boston to learn about new technologies and approaches in improving stability and payload release for ADCs. Gain the knowledge to develop homogenous ADCs with better efficacy and lower toxicity for patient benefit.
Timings09:00 AM-06:00 PM (expected)
Entry FeesCheck Official Website
Estimated Turnout100 - 500
DelegatesBased on previous editions
Frequency Not Available
Claim this event
Queries about the event? Ask Organizer
457 Total Events • 136 Followers
How did you participate in this event?
Followers [ Users who have shown interest for this Event ] Join Community Invite